Publication | Closed Access
Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma
17
Citations
16
References
2017
Year
Endocrine-related CancerMedicineThyroid DiseasePathologySomatostatin ReceptorThyroid HormoneMedullary Thyroid CarcinomaOncologyRadiation OncologyTumor MicroenvironmentCancer ResearchBetter Response
| Year | Citations | |
|---|---|---|
Page 1
Page 1